At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
FLAIR™ Endovascular Stent Graftdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Observational Study of the FLAIR™ Endovascular Stent Graft Optimized Delivery System
In Brief
A clinical study evaluating FLAIR™ Endovascular Stent Graft for Constriction, Pathologic. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The objective of this clinical study is to evaluate the performance of the Optimized FLAIR™ Delivery System.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsConstriction, Pathologic
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2007
Primary CompletionFeb 2008
First PostedFeb 2008
TodayJul 2026
First PostedFeb 13, 2008
Enrollment StartDec 1, 2007
Primary CompletionFeb 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 18.4 years ago
Interventions
FLAIR™ Endovascular Stent Graftdevice
The FLAIR™ Endovascular Stent Graft is designed to treat venous anastomotic stenoses of AV access grafts, providing both structural support of the site following angioplasty (stent), and a barrier to locally recurrent flow-limiting neointimal tissue growth (covering/graft).